E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4 Stage:E48
E5	Condition:T5 Name:T6
E8	Condition:T8 Name:T9
E10	Condition:T10 Name:T11
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16
E17	Condition:T17 Name:T18
E19	Condition:T19 Name:T20
E21	Condition:T21 Name:T22
E23	Condition:T23 Name:T24
E26	Age:T38 Numeric-Filter:E20
E27	Eq-Comparison:T50 Operator:T28 Temporal-Unit:T35 Value:T40
E28	Eq-Comparison:T51 Operator:T29 Value:T41
E29	Eq-Comparison:T52 Operator:T31 Value:T44 Temporal-Unit:T129
E30	Eq-Comparison:T53 Operator:T32 Temporal-Unit:T37 Value:T48
E31	Eq-Comparison:T54 Operator:T33 Value:T49
E32	Eq-Comparison:T55 Temporal-Period:T56
E2	Condition:T61 Name:T62
E4	Condition:T63 Name:T64
E6	Modifier:T65 Modifies:T64
E9	Eq-Comparison:T67 Temporal-Recency:T68
E11	Eq-Comparison:T69 Temporal-Period:T70
E12	Procedure:T71 Temporality:E9 Temporality2:E11
E14	Drug:T72 Name:T73
E18	Modifier:T27 Modifies:T73
E20	Eq-Comparison:T75 Operator:T76 Value:T39 Temporal-Unit:T34
E22	Assertion:T77 
E24	Study:T59 
E35	Observation:T78 Specimen:T80 Name:T79
E36	Assertion:T81 Asserted:E35
E37	Observation:T82 Name:T83
E38	Observation:T84 Name:T85
E40	Assertion:T87 Asserted:E37 Asserted2:E38
E41	Observation:T88 Name:T89 Numeric-Filter:E27
E42	Observation:T90 Name:T91
E43	Observation:T92 Name:T93
E45	Assertion:T95 Asserted:E42 Asserted2:E43
E46	Condition:T96 Name:T97
E47	Observation:T98 Name:T99 Numeric-Filter:E28
E48	Eq-Comparison:T100 Operator:T30 Unit:T101 Value:T42
E49	Criteria-Count:T102 Min-Value:E50 Criteria:E51 Criteria2:E52 Criteria3:E1 Criteria4:E10 Criteria5:E53 Criteria6:E5 Criteria7:E8
E50	Eq-Comparison:T103 Value:T104
E51	Condition:T105 Name:T106
E52	Condition:T107 Name:T108
E53	Condition:T109 Name:T110
E54	Drug:T112 Name:T113 Stability:T111
E55	Drug:T114 Name:T115 Stability:T111
E56	Drug:T116 Name:T117 Stability:T111
E59	Eq-Comparison:T120 Temporal-Period:T121 Value:T43 Temporal-Unit:T36
E61	Study:T123 
E63	Drug:T125 Name:T126
E64	Drug:T127 Name:T128 Temporality:E29
E65	Study:T130 Temporality:E66
E66	Eq-Comparison:T131 Temporal-Recency:T132
E68	Condition:T134 
E69	Observation:T135 Name:T136 Stability:T137
E70	Condition:T138 Name:T139
E71	Observation:T140 Name:T141 Stability:T142
E72	Exception:T143 From:E71 Except:E19
E74	Coreference:T145 Refers-To:E13
E75	Condition:T146 Name:T147 Temporality:E32
E76	Condition:T148 Name:T149
E77	Other:T150 Is-Other:E76
E79	Condition:T45 Name:T46
E25	Observation:T25 Name:T26 Stability:T152 Temporality:E30
E81	Study:T153 
E83	Observation:T155 Name:T156 Numeric-Filter:E31
E84	Condition:T157 Name:T158
E33	Drug:T57 
E85	Modifier:T58 Modifies:E33
T1	Condition 800 821	cognitive disturbance
T2	Condition-Name 800 821	cognitive disturbance
T3	Condition 640 665	Central Nervous Disorders
T4	Condition-Name 640 665	Central Nervous Disorders
T5	Condition 866 883	memory impairment
T6	Condition-Name 866 883	memory impairment
T7	Life-Stage-And-Gender 32 45	male patients
T8	Condition 885 896	hypersomnia
T9	Condition-Name 885 896	hypersomnia
T10	Condition 823 830	amnesia
T11	Condition-Name 823 830	amnesia
T12	Language 451 456	Dutch
T13	Condition 1206 1227	psychiatric disorders
T14	Condition-Name 1206 1227	psychiatric disorders
T15	Condition 1185 1204	Parkinson's disease
T16	Condition-Name 1185 1204	Parkinson's disease
T17	Condition 1166 1183	Alzheimer disease
T18	Condition-Name 1166 1183	Alzheimer disease
T19	Condition 1261 1271	depression
T20	Condition-Name 1261 1271	depression
T21	Condition 1275 1282	anxiety
T22	Condition-Name 1275 1282	anxiety
T23	Condition 1501 1508	anaemia
T24	Condition-Name 1501 1508	anaemia
T28	Eq-Operator 396 397	>
T29	Eq-Operator 601 602	≤
T30	Eq-Operator 627 628	≥
T31	Eq-Operator 1062 1068	within
T32	Eq-Operator 1448 1454	within
T33	Eq-Operator 1525 1526	<
T34	Eq-Temporal-Unit 144 149	years
T35	Eq-Temporal-Unit 400 406	months
T36	Eq-Temporal-Unit 989 994	weeks
T37	Eq-Temporal-Unit 1457 1462	weeks
T38	Age 128 131	Age
T39	Eq-Value 141 143	18
T40	Eq-Value 398 399	6
T41	Eq-Value 602 604	14
T42	Eq-Value 634 635	1
T43	Eq-Value 987 988	2
T44	Eq-Value 1069 1070	1
T48	Eq-Value 1455 1456	4
T49	Eq-Value 1526 1528	20
T50	Eq-Comparison 396 406	> 6 months
T51	Eq-Comparison 601 604	≤14
T52	Eq-Comparison 1062 1075	within 1 week
T53	Eq-Comparison 1448 1462	within 4 weeks
T54	Eq-Comparison 1525 1528	<20
T55	Eq-Comparison 1322 1328	Active
T56	Eq-Temporal-Period 1322 1328	Active
T61	Condition 25 30	Frail
T62	Condition-Name 25 30	Frail
T63	Condition 60 66	cancer
T64	Condition-Name 60 66	cancer
T65	Modifier 51 59	prostate
T67	Eq-Comparison 76 81	start
T68	Eq-Temporal-Recency 76 81	start
T69	Eq-Comparison 71 75	will
T70	Eq-Temporal-Period 71 75	will
T71	Procedure 82 91	treatment
T72	Drug 97 109	enzalutamide
T73	Drug-Name 97 109	enzalutamide
T27	Modifier 110 122	within label
T75	Eq-Comparison 132 149	at least 18 years
T76	Eq-Operator 132 140	at least
T77	Assertion 171 187	able and willing
T59	Study 230 239	screening
T78	Observation 290 303	blood samples
T79	Observation-Name 296 303	samples
T80	Specimen 290 295	blood
T81	Assertion 270 289	possible to collect
T82	Observation 348 362	questionnaires
T83	Observation-Name 348 362	questionnaires
T84	Observation 367 371	test
T85	Observation-Name 367 371	test
T87	Assertion 326 336	willing to
T88	Observation 377 392	Life expectancy
T89	Observation-Name 377 392	Life expectancy
T90	Observation 457 462	tests
T91	Observation-Name 457 462	tests
T92	Observation 467 481	questionnaires
T93	Observation-Name 467 481	questionnaires
T95	Assertion 412 422	Capable of
T96	Condition 519 524	Frail
T97	Condition-Name 519 524	Frail
T98	Observation 574 587	G8 assessment
T99	Observation-Name 574 587	G8 assessment
T100	Eq-Comparison 627 635	≥grade 1
T101	Eq-Unit 628 633	grade
T102	Criteria-Count 750 763	the following
T103	Eq-Comparison 743 746	one
T104	Eq-Value 743 746	one
T105	Condition 765 772	Fatigue
T106	Condition-Name 765 772	Fatigue
T107	Condition 774 798	Concentration impairment
T108	Condition-Name 774 798	Concentration impairment
T109	Condition 832 864	depressed level of consciousness
T110	Condition-Name 832 864	depressed level of consciousness
T111	Stability 923 929	change
T112	Drug 941 948	opioids
T113	Drug-Name 941 948	opioids
T114	Drug 949 958	sedatives
T115	Drug-Name 949 958	sedatives
T116	Drug 959 974	benzodiazepines
T117	Drug-Name 959 974	benzodiazepines
T120	Eq-Comparison 982 994	last 2 weeks
T121	Eq-Temporal-Period 982 986	last
T123	Study 1002 1007	study
T125	Drug 1021 1037	psychostimulants
T126	Drug-Name 1021 1037	psychostimulants
T127	Drug 1046 1061	methylphenidate
T128	Drug-Name 1046 1061	methylphenidate
T129	Eq-Temporal-Unit 1071 1075	week
T130	Study 1088 1093	study
T131	Eq-Comparison 1079 1084	start
T132	Eq-Temporal-Recency 1079 1084	start
T134	Condition 1114 1132	medical conditions
T135	Observation 1145 1154	cognition
T136	Observation-Name 1145 1154	cognition
T137	Stability 1138 1144	affect
T138	Condition 1156 1164	Dementia
T139	Condition-Name 1156 1164	Dementia
T140	Observation 1240 1249	cognition
T141	Observation-Name 1240 1249	cognition
T142	Stability 1233 1239	affect
T143	Exception 1250 1260	other than
T145	Coreference 1305 1316	the disease
T146	Condition 1329 1338	infection
T147	Condition-Name 1329 1338	infection
T148	Condition 1348 1361	comorbidities
T149	Condition-Name 1348 1361	comorbidities
T150	Other 1342 1347	other
T45	Condition 1420 1427	fatigue
T46	Condition-Name 1420 1427	fatigue
T25	Observation 1431 1440	cognition
T26	Observation-Name 1431 1440	cognition
T152	Stability 1441 1447	change
T153	Study 1466 1471	study
T155	Observation 1514 1524	MoCa score
T156	Observation-Name 1514 1524	MoCa score
T157	Condition 1534 1550	Hypersensitivity
T158	Condition-Name 1534 1550	Hypersensitivity
T57	Drug 1558 1574	active substance
T58	Modifier 1581 1602	any of the excipients
A1	Life-Stage-And-Gender-Type T7 male
A3	Eq-Operator-Value T28 GT
A4	Eq-Operator-Value T29 LTEQ
A5	Eq-Operator-Value T30 GTEQ
A6	Eq-Operator-Value T31 LTEQ
A7	Eq-Operator-Value T32 LTEQ
A8	Eq-Operator-Value T33 LT
A9	Eq-Temporal-Unit-Value T34 year
A10	Eq-Temporal-Unit-Value T35 month
A11	Eq-Temporal-Unit-Value T36 week
A12	Eq-Temporal-Unit-Value T37 week
A13	Eq-Temporal-Period-Value T56 present
A17	Eq-Temporal-Recency-Value T68 first-time
A16	Eq-Temporal-Period-Value T70 future
A2	Eq-Operator-Value T76 GTEQ
A18	Assertion-Type-Value E22 hypothetical
A19	Observation-Type-Value E35 lab
A20	Assertion-Type-Value E36 hypothetical
A21	Observation-Type-Value E37 survey-or-questionnaire
A22	Assertion-Type-Value E40 hypothetical
A23	Observation-Type-Value E43 survey-or-questionnaire
A24	Assertion-Type-Value E45 hypothetical
A25	Observation-Type-Value E47 clinical-score
A26	Stability-Value T111 change
A27	Eq-Temporal-Period-Value T121 past
A30	Eq-Temporal-Unit-Value T129 week
A31	Eq-Temporal-Recency-Value T132 first-time
A33	Stability-Value T137 change
A34	Stability-Value T142 change
A35	Stability-Value T152 change
A37	Observation-Type-Value E83 clinical-score
R1	Using Arg1:E12 Arg2:E14
R2	Example-Of Arg1:E64 Arg2:E63
R3	Caused-By Arg1:T137 Arg2:E68
R4	Example-Of Arg1:E70 Arg2:E68
R5	Example-Of Arg1:E17 Arg2:E68
R6	Example-Of Arg1:E15 Arg2:E68
R7	Example-Of Arg1:E13 Arg2:E68
R8	Caused-By Arg1:T142 Arg2:E13
R9	Caused-By Arg1:E21 Arg2:E74
R10	Caused-By Arg1:E19 Arg2:E74
R11	Caused-By Arg1:E84 Arg2:E33
R12	And Arg1:T7 Arg2:E4
R13	And Arg1:E4 Arg2:E12
R14	And Arg1:E37 Arg2:E38
R15	And Arg1:E42 Arg2:E43
R16	Or Arg1:E54 Arg2:E55
R17	Or Arg1:E55 Arg2:E56
R18	During Arg1:E56 Arg2:E59
R19	Before Arg1:E59 Arg2:E61
R20	Before Arg1:E29 Arg2:E66
R21	Or Arg1:E19 Arg2:E21
R22	Or Arg1:E75 Arg2:E76
R23	Or Arg1:E79 Arg2:E25
R24	Before Arg1:E30 Arg2:E81
R25	Or Arg1:E33 Arg2:E85
R26	Or Arg1:E1 Arg2:E10
R27	Or Arg1:E5 Arg2:E8
R28	Or Arg1:E10 Arg2:E53
R29	Or Arg1:E15 Arg2:E13
R30	Or Arg1:E17 Arg2:E15
R31	Or Arg1:E51 Arg2:E52
R32	Or Arg1:E52 Arg2:E1
R33	Or Arg1:E53 Arg2:E5
R34	Or Arg1:E70 Arg2:E17
